Suppr超能文献

开发健康体验的催化剂薄膜:对一个稳健的多利益相关者参与过程的分析。

Developing catalyst films of health experiences: an analysis of a robust multi-stakeholder involvement journey.

作者信息

Davis Sarah, Pandhi Nancy, Warren Barbara, Grevious Njeri, Crowder Madison, Ingersoll Haley, Perry Elizabeth, Sussman Andrew, Grob Rachel

机构信息

Center for Patient Partnerships, University of Wisconsin-Madison, 432 Lake St. Ste. 104, Madison, WI, 53706, USA.

Primary Care Academics Transforming Healthcare (PATH), UW-Madison, Madison, USA.

出版信息

Res Involv Engagem. 2022 Jul 29;8(1):34. doi: 10.1186/s40900-022-00369-3.

Abstract

BACKGROUND

Those whose lives are most directly impacted by health care-patients, caregivers, and frontline staff-are ideally situated to improve patient health care services and care quality. Despite a proliferation of literature on both Patient and Public Involvement (PPI) and clinical quality improvement (QI), concrete strategies regarding how to involve patients remain elusive.

AIM

Research suggests catalyst films, comprised of rigorously-analyzed interview data from diverse patients about their experiences with health and health care ("catalyst films") are a promising way to bring actionable patient feedback to QI. To date, such films have been crafted primarily by researchers. This project aimed to inform the science of engagement through analyzing how deliberate PPI informed the process of creating catalyst films.

METHODS

PPI methods included: research team norming activities through a project charter and role delineation process; key informant interviews; participant-ambassador videotaped interviews; clinician and research focus groups; and inclusion of advisors on the research team. Content studied for the analysis presented here included team meeting notes, interview and focus group transcripts, and documentation from a facilitated discussion about team processes. These data were analyzed to determine the impact of our PPI process. Member checking verified themes and lessons learned.

RESULTS

PPI shaped team deliberations and final products in substantial ways, including: what material to include in catalyst films and the tone they should convey; multiple issues regarding representation; and our collective understanding of how catalyst films could be used in the United States. Specific discussions addressed: how to include the optimal mix of interview segments that describe experiences with those that more directly point towards care improvement strategies; and how to balance positive and negative feedback from patients about experiences with care. Team process issues included ensuring equity in involvement despite team members having differing and sometimes multiple roles that complicated power dynamics and processes.

CONCLUSIONS

Multiple forms and degrees of PPI resulted in significant influence on catalyst films and companion materials. Our project thus provides proof of concept for PPI in creation of video products for QI which have traditionally been crafted by researchers. The model we developed, and document in this paper, can be adapted by others creating research-derived video products. Our findings can also inform future research on how co-designing catalyst films enhances their value for QI and the application of co-designed catalyst film use in QI. Lastly, it can guide those engaged in QI and medical education in their selection of film products focused on patient experiences.

摘要

背景

那些其生活受到医疗保健最直接影响的人群——患者、护理人员和一线工作人员——在改善患者医疗服务和护理质量方面处于理想位置。尽管关于患者及公众参与(PPI)和临床质量改进(QI)的文献大量涌现,但关于如何让患者参与的具体策略仍然难以捉摸。

目的

研究表明,由来自不同患者关于其健康和医疗保健经历的经过严格分析的访谈数据组成的催化剂影片(“催化剂影片”)是将可操作的患者反馈引入质量改进的一种有前景的方式。迄今为止,此类影片主要由研究人员制作。本项目旨在通过分析精心设计的患者及公众参与如何为制作催化剂影片的过程提供信息,为参与科学提供参考。

方法

患者及公众参与方法包括:通过项目章程和角色划分过程进行研究团队规范活动;关键信息提供者访谈;参与者 - 大使录像访谈;临床医生和研究焦点小组;以及在研究团队中纳入顾问。此处分析所研究的内容包括团队会议记录、访谈和焦点小组记录,以及关于团队流程的一次促进性讨论的文档。对这些数据进行分析以确定我们的患者及公众参与过程的影响。成员核对验证了主题和经验教训。

结果

患者及公众参与在很大程度上塑造了团队讨论和最终产品,包括:催化剂影片应包含的内容及其应传达的语气;关于代表性的多个问题;以及我们对催化剂影片在美国如何使用的集体理解。具体讨论的内容包括:如何在描述经历的访谈片段与更直接指向护理改进策略的片段之间实现最佳组合;以及如何平衡患者对护理经历的正面和负面反馈。团队流程问题包括,尽管团队成员角色不同且有时角色多样,这使权力动态和流程变得复杂,但仍要确保参与的公平性。

结论

多种形式和程度的患者及公众参与对催化剂影片及配套材料产生了重大影响。因此,我们的项目为患者及公众参与在为质量改进创建视频产品方面提供了概念验证,而这类视频产品传统上是由研究人员制作的。我们开发并在本文中记录的模型可供其他制作源自研究的视频产品的人采用。我们的研究结果还可为未来关于共同设计催化剂影片如何提高其对质量改进的价值以及共同设计的催化剂影片在质量改进中的应用的研究提供参考。最后,它可以指导那些从事质量改进和医学教育的人员在选择关注患者体验的影片产品时做出决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6b/9336058/1e4d425b49d1/40900_2022_369_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验